Associations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study
dc.contributor.author | Jackson, Colette E. | en_US |
dc.contributor.author | MacDonald, Michael R. | en_US |
dc.contributor.author | Petrie, Mark C. | en_US |
dc.contributor.author | Solomon, Scott D. | en_US |
dc.contributor.author | Pitt, Bertram | en_US |
dc.contributor.author | Latini, Roberto | en_US |
dc.contributor.author | Maggioni, Aldo P. | en_US |
dc.contributor.author | Smith, Beverly A. | en_US |
dc.contributor.author | Prescott, Margaret F. | en_US |
dc.contributor.author | Lewsey, Jim | en_US |
dc.contributor.author | McMurray, John J.V. | en_US |
dc.date.accessioned | 2014-03-05T18:19:05Z | |
dc.date.available | 2014-03-05T18:19:05Z | |
dc.date.issued | 2011-07 | en_US |
dc.identifier.citation | Jackson, Colette E.; MacDonald, Michael R.; Petrie, Mark C.; Solomon, Scott D.; Pitt, Bertram; Latini, Roberto; Maggioni, Aldo P.; Smith, Beverly A.; Prescott, Margaret F.; Lewsey, Jim; McMurray, John J.V. (2011). "Associations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study." European Journal of Heart Failure 13(7): 746-754. <http://hdl.handle.net/2027.42/106114> | en_US |
dc.identifier.issn | 1388-9842 | en_US |
dc.identifier.issn | 1879-0844 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/106114 | |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.subject.other | Albuminuria | en_US |
dc.subject.other | Heart Failure | en_US |
dc.subject.other | Proteins | en_US |
dc.subject.other | Kidney | en_US |
dc.title | Associations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Cardiovascular Medicine | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.identifier.pmid | 21459891 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/106114/1/ejhfhfr031.pdf | |
dc.identifier.doi | 10.1093/eurjhf/hfr031 | en_US |
dc.identifier.source | European Journal of Heart Failure | en_US |
dc.identifier.citedreference | de Zeeuw D Parving HH Henning RH Microalbuminuria as an early marker for cardiovascular disease J Am Soc Nephrol 2006 17 2100 2105 | en_US |
dc.identifier.citedreference | Jackson CE Solomon SD Gerstein HC Zetterstrand S Olofsson B Michelson EL Granger CB Swedberg K Pfeffer MA Yusuf S McMurray JJV Albuminuria in chronic heart failure: prevalence and prognostic importance Lancet 2009 374 543 550 | en_US |
dc.identifier.citedreference | Masson S Latini R Milani V Moretti L Rossi MG Carbonieri E Frisinghelli A Minneci C Valisi M Maggioni AP Marchioli R Tognoni G Tavazzi L GISSI‐HF Investigators Prevalence and prognostic value of elevated urinary albumin excretion in patients with chronic heart failure: data from the GISSI‐Heart Failure trial Circ Heart Fail 2010 3 65 72 | en_US |
dc.identifier.citedreference | Deckert T Feldt‐Rasmussen B Borch‐Johnsen K Jensen T Kofoed‐Enevoldsen A Albuminuria reflects widespread vascular damage. The Steno hypothesis Diabetologia 1989 32 219 226 | en_US |
dc.identifier.citedreference | Weir MR Microalbuminuria and cardiovascular disease Clin J Am Soc Nephrol 2007 2 581 590 | en_US |
dc.identifier.citedreference | Silverberg D Wexler D Blum M Schwartz D Iaina A The association between congestive heart failure and chronic renal disease Curr Opin Nephrol Hypertens 2004 13 163 170 | en_US |
dc.identifier.citedreference | Smilde TD Damman K van der Harst P Navis G Westenbrink BD Voors AA Boomsma F van Veldhuisen DJ Hillege HL Differential associations between renal function and ‘modifiable’ risk factors in patients with chronic heart failure Clin Res Cardiol 2009 98 121 129 | en_US |
dc.identifier.citedreference | Birn H Christensen EI Renal albumin absorption in physiology and pathology Kidney Int 2006 69 440 449 | en_US |
dc.identifier.citedreference | Hebert K Dias A Delgado MC Franco E Tamariz L Steen D Trahan P Major B Arcement LM Epidemiology and survival of the five stages of chronic kidney disease in a systolic heart failure population Eur J Heart Fail 2010 12 861 865 | en_US |
dc.identifier.citedreference | Scrutinio D Passantino A Santoro D Catanzaro R The cardiorenal anaemia syndrome in systolic heart failure: prevalence, clinical correlates, and long‐term survival Eur J Heart Fail 2011 13 61 67 | en_US |
dc.identifier.citedreference | Damman K Voors AA Hillege HL Navis G Lechat P van Veldhuisen DJ Dargie HJ CIBIS‐2 Investigators and Committees Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality Eur J Heart Fail 2010 12 974 982 | en_US |
dc.identifier.citedreference | McMurray JJV Pitt B Latini R Maggioni AP Solomon SD Keefe DL Ford J Verma A Lewsey J for the Aliskiren Observation of Heart Failure Treatment (ALOFT) Investigators Circ Heart Fail 2008 1 17 24 | en_US |
dc.identifier.citedreference | National Kidney Association K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 2002 39 2 Suppl 1 S1 266 | en_US |
dc.identifier.citedreference | IDF Clinical Guidelines Task Force Global guideline for Type 2 diabetes: recommendations for standard, comprehensive, and minimal care Diabetes Med 2006 23 579 593 | en_US |
dc.identifier.citedreference | Solomon SD Lin J Solomon CG Jablonski KA Rice MM Steffes M Domanski M Hsia J Gersh BJ Arnold JM Rouleau J Braunwald E Pfeffer MA Prevention of Events With ACE Inhibition (PEACE) Investigators Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease Circulation 2007 116 2687 2693 | en_US |
dc.identifier.citedreference | Astor BC Hallan SI Miller ER 3rd Yeung E Coresh J Glomerular filtration rate, albuminuria, and risk of cardiovascular and all‐cause mortality in the US population Am J Epidemiol 2008 167 1226 1234 | en_US |
dc.identifier.citedreference | Diercks GF van Boven AJ Hillege HL Janssen WM Kors JA de Jong PE Grobbee DE Crijns HJ van Gilst WH Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non‐diabetic population. The PREVEND (Prevention of Renal and Vascular ENdstage Disease) study Eur Heart J 2000 21 1922 1927 | en_US |
dc.identifier.citedreference | Gerstein HC Mann JF Yi Q Zinman B Dinneen SF Hoogwerf B Hallé JP Young J Rashkow A Joyce C Nawaz S Yusuf S HOPE Study Investigators Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals JAMA 2001 286 421 426 | en_US |
dc.identifier.citedreference | Schmieder RE Schrader J Zidek W Tebbe U Paar WD Bramlage P Pittrow D Böhm M Low‐grade albuminuria and cardiovascular risk: what is the evidence? Clin Res Cardiol 2007 96 247 257 | en_US |
dc.identifier.citedreference | Wattanakit K Folsom AR Criqui MH Kramer HJ Cushman M Shea S Hirsch AT Albuminuria and peripheral arterial disease: results from the Multi‐Ethnic Study of Atherosclerosis (MESA) Atherosclerosis 2008 15 February, epub ahead of print | en_US |
dc.identifier.citedreference | Kshirsagar AV Bomback AS Bang H Gerber LM Vupputuri S Shoham DA Mazumdar M Ballantyne CM Paparello JJ Klemmer PJ Association of C‐reactive protein and microalbuminuria (from the National Health and Nutrition Examination Surveys, 1999 to 2004) Am J Cardiol 2008 101 401 406 | en_US |
dc.identifier.citedreference | McLay JS McMurray JJ Bridges AB Fraser CG Struthers AD Acute effects of captopril on the renal actions of furosemide in patients with chronic heart failure Am Heart J 1993 126 879 886 | en_US |
dc.identifier.citedreference | Vesely DL Perez‐Lamboy GI Schocken DD Long‐acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance urinary excretion rate of albumin, total protein, and beta(2)‐ microglobulin in patients with congestive heart failure J Card Fail 2001 7 55 63 | en_US |
dc.identifier.citedreference | Wegria R Capeci NE Blumenthal MR Kornfeld P Hays DR Elias RA Hilton JG The pathogenesis of proteinuria in the acutely congested kidney J Clin Invest 1955 34 737 743 | en_US |
dc.identifier.citedreference | Parving HH Persson F Lewis JB Lewis EJ Hollenberg NK for the AVOID Study Investigators Aliskiren combined with losartan in Type 2 diabetes and nephropathy N Engl J Med 2008 358 2433 2446 | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.